Free Trial

NOV (NOV) Stock Forecast & Price Target

$18.25
-0.39 (-2.09%)
(As of 07/24/2024 ET)

NOV - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 15 Wall Street analysts who have issued ratings for NOV in the last 12 months, the stock has a consensus rating of "Hold." Out of the 15 analysts, 2 have given a sell rating, 4 have given a hold rating, and 9 have given a buy rating for NOV.

Consensus Price Target

$24.07
31.90% Upside
High Forecast$33.00
Average Forecast$24.07
Low Forecast$18.00

According to the 15 analysts' twelve-month price targets for NOV, the average price target is $24.07. The highest price target for NOV is $33.00, while the lowest price target for NOV is $18.00. The average price target represents a forecasted upside of 31.90% from the current price of $18.25.

TypeCurrent Forecast
7/26/23 to 7/25/24
1 Month Ago
6/26/23 to 6/25/24
3 Months Ago
4/27/23 to 4/26/24
1 Year Ago
7/26/22 to 7/26/23
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
9 Buy rating(s)
8 Buy rating(s)
8 Buy rating(s)
8 Buy rating(s)
Hold
4 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
6 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$24.07$24.07$24.36$24.07
Forecasted Upside31.90% Upside25.90% Upside27.99% Upside17.56% Upside
Get NOV Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NOV and its competitors with MarketBeat's FREE daily newsletter.

NOV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NOV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

NOV Stock vs. The Competition

TypeNOVBusiness Services CompaniesS&P 500
Consensus Rating Score
2.47
2.64
2.51
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside31.90% Upside163.13% Upside10.61% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/15/2024Bank of America
4 of 5 stars
 Lower TargetBuy ➝ Buy$24.00 ➝ $22.00+14.52%
7/15/2024Piper Sandler
2 of 5 stars
 Lower TargetNeutral ➝ Neutral$22.00 ➝ $20.00+7.99%
4/29/2024TD Cowen
4 of 5 stars
 Lower TargetBuy ➝ Buy$27.00 ➝ $26.00+37.78%
4/8/2024Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingPositive ➝ Positive$26.00+26.89%
2/6/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingSector Perform ➝ Sector Perform$24.00+39.13%
2/5/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$28.00 ➝ $26.00+50.29%
2/5/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$28.00 ➝ $25.00+41.88%
1/16/2024Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
12/22/2023ATB Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Set TargetOutperform$33.00+60.51%
12/8/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$22.00 ➝ $25.00+35.50%
10/17/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$24.00 ➝ $25.00+19.79%
10/17/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeEqual Weight ➝ Underweight$20.00-2.44%
10/3/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$20.00 ➝ $21.00+3.45%
8/9/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSell ➝ Sell$16.00 ➝ $18.00-12.15%
7/31/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$21.00 ➝ $26.00+34.37%
7/14/2023Capital One Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Becker
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$20.00+8.23%
2/8/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$26.00 ➝ $27.00+16.03%
11/7/2022Redburn Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight$25.00+4.21%
10/31/2022Susquehanna Bancshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$27.00 ➝ $25.00+15.85%
8/8/2022Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Curran
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:00 AM ET.

NOV Forecast - Frequently Asked Questions

What is NOV's forecast for 2024?

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for NOV is $24.07, with a high forecast of $33.00 and a low forecast of $18.00.

Should I buy or sell NOV stock right now?

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NOV in the last twelve months. There are currently 2 sell ratings, 4 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NOV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NOV, but not buy additional shares or sell existing shares.

Does NOV's stock price have much upside?

According to analysts, NOV's stock has a predicted upside of 24.92% based on their 12-month stock forecasts.

What analysts cover NOV?

NOV has been rated by research analysts at Bank of America, Piper Sandler, and TD Cowen in the past 90 days.

Do Wall Street analysts like NOV more than its competitors?

Analysts like NOV less than other "business services" companies. The consensus rating for NOV is Hold while the average consensus rating for "business services" companies is Moderate Buy. Learn more on how NOV compares to other companies.


This page (NYSE:NOV) was last updated on 7/25/2024 by MarketBeat.com Staff

From Our Partners